PHARMA-BIO SERV, INC. Accumulated Other Comprehensive Income
PHARMA-BIO SERV, INC. (PBSV) had Accumulated Other Comprehensive Income of $251.24 thousand as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-09-14
- 2026-07-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $251.24K.
- 2026-04-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $254.96K.
- 2026-01-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $280.36K.
- 2025-10-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $278.05K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-07-31 | $251.24K 10-Q · filed 2026-09-14 |
| 2026-04-30 | $254.96K 10-Q · filed 2026-06-15 |
| 2026-01-31 | $280.36K 10-Q · filed 2026-03-17 |
| 2025-10-31 | $278.05K 10-Q · filed 2026-09-14 |
| 2025-07-31 | $285.58K 10-Q · filed 2025-09-15 |
| 2025-04-30 | $282.95K 10-Q · filed 2025-06-16 |
| 2025-01-31 | $243.88K 10-Q · filed 2025-03-17 |
| 2024-10-31 | $262.38K 10-K · filed 2026-01-29 |
| 2024-07-31 | $253.28K 10-Q · filed 2024-09-16 |
| 2024-04-30 | $223.54K 10-Q · filed 2024-06-14 |
| 2024-01-31 | $225.21K 10-Q · filed 2024-03-18 |
| 2023-10-31 | $210.27K 10-K · filed 2025-01-29 |
| 2023-07-31 | $221.71K 10-Q · filed 2023-09-14 |
| 2023-04-30 | $246.31K 10-Q · filed 2023-06-14 |
| 2023-01-31 | $229.69K 10-Q · filed 2023-03-17 |
| 2022-10-31 | $238.15K 10-K · filed 2024-01-29 |
| 2022-07-31 | $28.62K 10-Q · filed 2022-09-14 |
| 2022-04-30 | $67.82K 10-Q · filed 2022-06-14 |
| 2022-01-31 | $118.96K 10-Q · filed 2022-03-17 |
| 2021-10-31 | $144.46K 10-K · filed 2023-01-30 |
| 2021-07-31 | $194.38K 10-Q · filed 2021-09-14 |
| 2021-04-30 | $189.15K 10-Q · filed 2021-06-14 |
| 2021-01-31 | $184.41K 10-Q · filed 2021-03-17 |
| 2020-10-31 | $160.65K 10-K · filed 2022-02-11 |
| 2020-07-31 | $180.86K 10-Q · filed 2020-09-14 |
| 2020-04-30 | $102.13K 10-Q · filed 2020-06-15 |
| 2020-01-31 | $131.87K 10-Q · filed 2020-03-16 |
| 2019-10-31 | $143.60K 10-K · filed 2021-02-01 |
| 2019-07-31 | $86.20K 10-Q · filed 2019-09-16 |
| 2019-04-30 | $92.52K 10-Q · filed 2019-06-14 |
| 2019-01-31 | $115.79K 10-Q · filed 2019-03-18 |
| 2018-10-31 | $107.95K 10-K · filed 2020-01-29 |
| 2018-07-31 | $131.05K 10-Q · filed 2018-09-14 |
| 2018-04-30 | $182.85K 10-Q · filed 2018-06-14 |
| 2018-01-31 | $218.95K 10-Q · filed 2018-03-19 |
| 2017-10-31 | $137.67K 10-K · filed 2019-01-29 |
| 2017-07-31 | -$121.67K 10-Q · filed 2017-09-14 |
| 2017-04-30 | -$161.53K 10-Q · filed 2017-06-14 |
| 2017-01-31 | -$160.53K 10-Q · filed 2017-03-17 |
| 2016-10-31 | -$165.91K 10-K · filed 2018-01-29 |
| 2016-07-31 | -$156.18K 10-Q · filed 2016-09-14 |
| 2016-04-30 | -$163.19K 10-Q · filed 2016-06-14 |
| 2016-01-31 | -$237.53K 10-Q · filed 2016-03-16 |
| 2015-10-31 | -$226.58K 10-K · filed 2017-01-31 |
| 2015-07-31 | -$226.59K 10-Q · filed 2015-09-14 |
| 2015-04-30 | -$206.87K 10-Q · filed 2015-06-15 |
| 2015-01-31 | -$183.72K 10-Q · filed 2015-03-17 |
| 2014-10-31 | -$135.71K 10-K · filed 2016-01-29 |
| 2014-07-31 | -$99.84K 10-Q · filed 2014-09-15 |
| 2014-04-30 | -$74.56K 10-Q · filed 2014-06-16 |
| 2014-01-31 | -$94.38K 10-Q · filed 2014-03-17 |
| 2013-10-31 | -$76.75K 10-K · filed 2015-01-29 |
| 2013-07-31 | -$84.55K 10-Q · filed 2013-09-16 |
| 2013-04-30 | -$94.51K 10-Q · filed 2013-06-14 |
| 2013-01-31 | -$63.06K 10-Q · filed 2013-03-18 |
| 2012-10-31 | -$91.42K 10-K · filed 2014-01-29 |
| 2012-07-31 | -$133.17K 10-Q · filed 2012-09-14 |
| 2012-04-30 | -$76.68K 10-Q · filed 2012-06-14 |
| 2012-01-31 | -$82.29K 10-Q · filed 2012-03-16 |
| 2011-10-31 | -$20.01K 10-K · filed 2013-01-29 |
| 2011-07-31 | -$8.44K 10-Q · filed 2011-09-14 |
| 2010-10-31 | -$19.22K 10-K/A · filed 2012-01-31 |